tiprankstipranks
Relmada Therapeutics Inc (DE:4E2)
NASDAQ:4E2

Compare Relmada Therapeutics (4E2) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Relmada Therapeutics
€4.40
€406.25M
-4.62
170.59%
3 Buy
0 Hold
0 Sell
Strong Buy
XBiotech
$2.30
$67.07M
-1.47
-20.44%
Prelude Therapeutics
$6.34
$435.73M
-6.71
324.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Spruce Biosciences
$63.40
$166.49M
-1.45
556.56%
5 Buy
0 Hold
0 Sell
Strong Buy
Werewolf Therapeutics
$0.89
$46.96M
-1.33
-26.32%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:4E2
Relmada Therapeutics
3.68
2.37
180.92%
XBIT
XBiotech
2.18
-0.61
-21.86%
RPTX
PRLD
Prelude Therapeutics
5.30
4.11
345.38%
SPRB
Spruce Biosciences
59.09
50.09
556.56%
HOWL
Werewolf Therapeutics
0.98
-0.39
-28.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts